The effect of 2’-fucosyllactose on simulated infant gut microbiome and metabolites

Background
Abstract

Using a semi-continuous colon simulator, effecot of an HMO, 2’-fucosyllactose (2’-FL), on composition of the infant microbiota and microbial metabolites was evaluated in comparison to galacto-oligosaccharide (GOS) and lactose and control without additional carbon source.

1 min read

Link to Publication: https://www.ncbi.nlm.nih.gov/pubmed/31520068

 

WYE-EM-396-DEC-19

Reference

Salli K et al. The effect of 2’-fucosyllactose on simulated infant gut microbiome and metabolites; a pilot study in comparison to GOS and lactose. Sci Rep. 2019;9(1):13232.
 

Other articles that you might be interested in:

Interview with Prof. Clemens Kunz – New insights on the role of human milk oligosaccharides (HMOs)

Locked
Off
FAB action liks
Share
Messenger
WhatsApp
Copy Link
Register
Off
Save (for later)
On
Share it

Hot topics